These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 29974381)

  • 41. Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.
    Brahmachari S; Ge P; Lee SH; Kim D; Karuppagounder SS; Kumar M; Mao X; Shin JH; Lee Y; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM; Ko HS
    J Clin Invest; 2016 Aug; 126(8):2970-88. PubMed ID: 27348587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application.
    Andresen L; Theodorou K; Grünewald S; Czech-Zechmeister B; Könnecke B; Lühder F; Trendelenburg G
    PLoS One; 2016; 11(2):e0148428. PubMed ID: 26849209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.
    Wu R; Chen H; Ma J; He Q; Huang Q; Liu Q; Li M; Yuan Z
    Cell Death Differ; 2016 Mar; 23(3):542-52. PubMed ID: 26517532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome.
    Wang X; Li R; Wang X; Fu Q; Ma S
    Neurosci Lett; 2015 Jul; 600():182-7. PubMed ID: 26071904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levo-tetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: Involvement of Src kinase.
    Mao XW; Pan CS; Huang P; Liu YY; Wang CS; Yan L; Hu BH; Chang X; He K; Mu HN; Li Q; Sun K; Fan JY; Han JY
    Sci Rep; 2015 Jun; 5():11155. PubMed ID: 26059793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
    Karuppagounder SS; Brahmachari S; Lee Y; Dawson VL; Dawson TM; Ko HS
    Sci Rep; 2014 May; 4():4874. PubMed ID: 24786396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling.
    Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and dynamic regulation of Abl kinases.
    Panjarian S; Iacob RE; Chen S; Engen JR; Smithgall TE
    J Biol Chem; 2013 Feb; 288(8):5443-50. PubMed ID: 23316053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats.
    Yue K; Ma B; Ru Q; Chen L; Gan Y; Wang D; Jin G; Li C
    Pharmacol Biochem Behav; 2012 Jul; 102(1):1-5. PubMed ID: 22741173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats.
    Han Y; Zhang W; Tang Y; Bai W; Yang F; Xie L; Li X; Zhou S; Pan S; Chen Q; Ferro A; Ji Y
    PLoS One; 2012; 7(6):e38627. PubMed ID: 22715398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.
    Wang JB; Mantsch JR
    Future Med Chem; 2012 Feb; 4(2):177-86. PubMed ID: 22300097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. c-Abl in neurodegenerative disease.
    Schlatterer SD; Acker CM; Davies P
    J Mol Neurosci; 2011 Nov; 45(3):445-52. PubMed ID: 21728062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases.
    Yasuda S; Sugiura H; Tanaka H; Takigami S; Yamagata K
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):45-59. PubMed ID: 20812905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The science of stroke: mechanisms in search of treatments.
    Moskowitz MA; Lo EH; Iadecola C
    Neuron; 2010 Jul; 67(2):181-98. PubMed ID: 20670828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Signaling by ROS drives inflammasome activation.
    Martinon F
    Eur J Immunol; 2010 Mar; 40(3):616-9. PubMed ID: 20201014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.
    Jung JE; Kim GS; Chen H; Maier CM; Narasimhan P; Song YS; Niizuma K; Katsu M; Okami N; Yoshioka H; Sakata H; Goeders CE; Chan PH
    Mol Neurobiol; 2010 Jun; 41(2-3):172-9. PubMed ID: 20157789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S; Ravindranath V
    J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptotic mechanisms after cerebral ischemia.
    Broughton BR; Reutens DC; Sobey CG
    Stroke; 2009 May; 40(5):e331-9. PubMed ID: 19182083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
    Hantschel O; Superti-Furga G
    Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.